U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Substance Class Protein
Created
by admin
on Sat Dec 16 14:57:26 UTC 2023
Edited
by admin
on Sat Dec 16 14:57:26 UTC 2023
Protein Sub Type
Sequence Type COMPLETE
Record UNII
2PDN1S3FVX
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA
Common Name English
PPAR-ALPHA
Common Name English
NUCLEAR RECEPTOR SUBFAMILY 1 GROUP C MEMBER 1
Common Name English
PPAR-.ALPHA.
Common Name English
PPARA
Common Name English
Code System Code Type Description
FDA UNII
2PDN1S3FVX
Created by admin on Sat Dec 16 14:57:30 UTC 2023 , Edited by admin on Sat Dec 16 14:57:30 UTC 2023
PRIMARY
UNIPROT
Q07869
Created by admin on Sat Dec 16 14:57:30 UTC 2023 , Edited by admin on Sat Dec 16 14:57:30 UTC 2023
PRIMARY
Related Record Type Details
Structure of K-111
ACTIVATOR -> TARGET
Structure of MURAGLITAZAR
AGONIST -> TARGET
Structure of MK-0767
AGONIST -> TARGET
Structure of NETOGLITAZONE
AGONIST -> TARGET
Structure of SODELGLITAZAR
AGONIST -> TARGET
Structure of CLOFIBRIC ACID
ACTIVATOR -> TARGET
Structure of GEMFIBROZIL
ACTIVATOR -> TARGET
Structure of LOBEGLITAZONE
AGONIST -> TARGET
Structure of ALEGLITAZAR
AGONIST -> TARGET
Structure of CEVOGLITAZAR
AGONIST -> TARGET
Structure of ABTL-0812
AGONIST -> TARGET
Ki=7.1 micromolar (Supplementary Fig. S5; http://clincancerres.aacrjournals.org/content/22/10/2508.figures-only)
IN-VITRO
IC50
Structure of CARFLOGLITAZAR
AGONIST -> TARGET
Structure of CHIGLITAZAR
INHIBITOR -> TARGET
Structure of CARFLOGLITAZAR, (R)-
WEAK AGONIST->TARGET
Structure of CP-778875
AGONIST -> TARGET
Structure of ERTIPROTAFIB
AGONIST -> TARGET
Structure of GEMCABENE
AGONIST -> TARGET
Structure of GSK-183390
INHIBITOR -> TARGET
Structure of PEMAGLITAZAR
AGONIST -> TARGET
Structure of SELADELPAR
WEAK AGONIST->TARGET
EC50
Structure of SIPOGLITAZAR
AGONIST -> TARGET
Structure of FENOFIBRIC ACID
AGONIST -> TARGET
Structure of RIVOGLITAZONE
AGONIST -> TARGET
SELECTIVE
Structure of AVE-0897
AGONIST -> TARGET
Structure of AVE-8134
AGONIST -> TARGET
Structure of ELAFIBRANOR
AGONIST -> TARGET
Structure of TESAGLITAZAR
AGONIST -> TARGET
Tesaglitazar is a novel dual-acting peroxisome proliferator-activated receptor alpha and gamma agonist.
Structure of PEMAFIBRATE
AGONIST -> TARGET
EC50
Structure of CI-924
ACTIVATOR -> TARGET
Structure of LY-510929
AGONIST -> TARGET
Structure of RAGAGLITAZAR
AGONIST -> TARGET
Structure of SAROGLITAZAR
AGONIST -> TARGET
Structure of NAVEGLITAZAR
AGONIST -> TARGET
Structure of OBETICHOLIC ACID
INHIBITOR -> TARGET
INHIBITOR
EC50
Structure of IMIGLITAZAR
AGONIST -> TARGET
Structure of INDEGLITAZAR
AGONIST -> TARGET
Structure of OXEGLITAZAR
AGONIST -> TARGET
Structure of GW-590735
ACTIVATOR -> TARGET
Structure of PF-00807925
AGONIST -> TARGET
Structure of REGLITAZAR
AGONIST -> TARGET
Structure of LANIFIBRANOR
AGONIST -> TARGET
AGONIST
EC50
Structure of PELIGLITAZAR
AGONIST -> TARGET
Structure of BMS-711939
AGONIST -> TARGET
The PPARα potency and selectivity of 3 were further confirmed by testing it in cotransfection assays in HepG2 cells using full length human PPARα and PPARγ receptors..
EC50
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966